干扰素诱发2型糖尿病转为1型糖尿病1例报告并文献复习
被引量:1
摘要
回顾性分析1例丙型肝炎合并2型糖尿病的临床资料及相关文献。在干扰素α-2b标准治疗12周时,出现血糖急剧升高,胰岛功能衰竭,胰岛细胞抗体阳性,诊断为1型糖尿病,改胰岛素治疗。
出处
《甘肃医药》
2015年第12期935-937,共3页
Gansu Medical Journal
参考文献15
-
1Bahtiyar G, Shin JJ, Aytaman A, et al. Association of diabetes andhepatitis C infection: epidemiologic evidence and pathophysiologic insights[J].Current Diabetes Reports,2004,4(3):194-198. 被引量:1
-
2Hsieh M J, Lan KP, Liu HY, et al. Hepa-titis C virus E2protein involve in insulin resistance through an impairment of Akt/PKB and GSK3beta signaling in hepatocytes [J]. BMC Gastroenterol, 2012,12 ( 1 ):74. 被引量:1
-
3Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-l/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes[ J ]. Hepatology,2003,38(6): 1384-1392. 被引量:1
-
4Kawaguchi T, Yoshida T, Harada M,et al. Hepatitis C virusdown- regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor ofcytokine signaling 3 [J]. The A-merican journal of pathology, 2004,165(5):1499-1508. 被引量:1
-
5Pazienza V, Clement S, Pugnale P, et al. The hepatitis C virus core protein of genotypes 3a and lb down regulates insulin receptor substrate 1 through genotype-specific mechanisms[J]. Hepatolo Gy, 2007,45(5):1164-1171. 被引量:1
-
6Bugianesi E, MeCullough AJ,Marchesini G. Insulin resistance:a metabolic pathway to chronic liver disease[J].Hepatology, 2005,42 (5):987-1000. 被引量:1
-
7Shoelson SE,Lee J,Yuan M.Inflammation and the IKK beta/l kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance [J].International Journal of Obesity, 2003, 27(Suppl 3) : S49-52. 被引量:1
-
8Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance [J]. Nature Medicine,2005,11 ( 2 ): 191 - 198. 被引量:1
-
9Gao TY,Qin ZL,Ren H, et al .Inhibition of IRS-I by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner [ J ] .Virology Journal,2015,12 ( 1 ): 12. 被引量:1
-
10Taiba Zornitzki,Stephen Malnick,Lyudmila Lysyy,Hilla Knobler.Interferon therapy in hepatitis Cleading to chronic type 1 diabetes[J].World Journal of Gastroenterology,2015,21(1):233-239. 被引量:17
二级参考文献20
-
1M.Recasens,E.Aguilera,S.Ampurdanés,J. M.Sánchez Tapias,O.Simó,R.Casamitjana,I.Conget.Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C[J]. Diabetic Medicine . 2008 (9) 被引量:2
-
2Manfred Wiese,Kurt Grüngreiff,Wolfgang Güthoff,Michael Lafrenz,Ute Oesen,Heiner Porst.Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study[J].Journal of Hepatology.2005(4) 被引量:2
-
3Mehta S H,Brancati F L,Sulkowski M S,Strathdee S A,Szklo M,Thomas D L.Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine . 2000 被引量:2
-
4Karvonen M,Viik-Kajander M,Moltchanova E,Libman I,LaPorte R,Tuomilehto J.Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care . 2000 被引量:2
-
5Mohammed Eyad Yaseen Alsabbagh,Naseem Eisa,Abdul Hamid Alraiyes,M Chadi Alraies.Chronic hepatitis C therapy: a rare complication revisited[J]. Case Reports . 2013 (jul2) 被引量:1
-
6Hiroaki Yagyu,Kenta Okada,Shin Sato,Yumiko Yamashita,Nobukazu Okada,Jun-ichi Osuga,Shoichiro Nagasaka,Kentaro Sugano,Shun Ishibashi.Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus[J]. Diabetes Research and Clinical Practice . 2011 (3) 被引量:1
-
7G. Scavone,F. Zaccardi,A. Manto,S. Caputo,D. Pitocco,G. Ghirlanda.A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy[J]. Diabetes Research and Clinical Practice . 2010 (2) 被引量:1
-
8Masayuki Hayashi,Yuko Kataoka,Kazushige Tachikawa,Hiroki Koguchi,Hiroshi Tanaka.Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C[J]. Diabetes Research and Clinical Practice . 2009 (2) 被引量:1
-
9G. Tosone,G. Borgia,I. Gentile,R. Cerini,M. C. D. Conte,R. Orlando,M. Piazza.A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?[J]. Acta Diabetologica . 2007 (3) 被引量:1
-
10Raffaele Cozzolongo,Corrado Betterle,Paolo Fabris,Maria Paola Albergoni,Elsa Lanzilotta,Onofrio G. Manghisi.Onset of type 1 diabetes mellitus during peginterferon α-2b plus ribavirin treatment for chronic hepatitis C[J]. European Journal of Gastroenterology & Hepatology . 2006 (6) 被引量:1
共引文献16
-
1无.丙型肝炎防治指南(2015年版)[J].中国肝脏病杂志(电子版),2015,7(3):19-35. 被引量:74
-
2无.丙型肝炎防治指南(2015年更新版)[J].中华实验和临床感染病杂志(电子版),2015,9(5):20-36. 被引量:69
-
3无.丙型肝炎防治指南(2015更新版)[J].中华肝脏病杂志,2015,23(12):906-923. 被引量:261
-
4陈红松,窦晓光,段钟平,侯金林,贾继东,李杰,李兰娟,鲁凤民,饶慧瑛,任红,盛吉芳,唐红,魏来,谢青,徐小元,尤红,张欣欣,赵景民,庄辉.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979. 被引量:225
-
5丙型肝炎防治指南(2015更新版)[J].中华临床感染病杂志,2015,8(6):504-525. 被引量:15
-
6Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.丙型肝炎防治指南(2015年更新版)[J].传染病信息,2016,29(1):1-19. 被引量:33
-
7窦晓光,白菡.重视慢性丙型肝炎合并其他系统疾病的诊治[J].中国实用内科杂志,2016,36(3):173-175. 被引量:2
-
8张曦,蔺淑梅.慢性丙型肝炎合并糖尿病的诊治[J].中国实用内科杂志,2016,36(3):176-179. 被引量:2
-
9无,魏来,侯金林,陈红松,窦晓光,段钟平,贾继东,李杰,李兰娟,鲁凤民,饶慧瑛,任红,盛吉芳,唐红,谢青,徐小元,尤红,张欣欣,赵景民,庄辉.丙型肝炎防治指南(2015年更新版)[J].泸州医学院学报,2016,39(2):95-113. 被引量:7
-
10无.《丙型肝炎防治指南》2015年更新版[J].实用肝脏病杂志,2016,19(4). 被引量:66
同被引文献6
-
1袁晓,倪海祥,魏佳平,吴巧敏.2型糖尿病中医证型与自身免疫性甲状腺疾病的关系研究[J].浙江中医药大学学报,2014,38(2):156-158. 被引量:10
-
2王彦江,谢席胜,冯胜刚,龙琼先.感染对糖尿病大鼠病理状态的影响[J].西部医学,2014,26(11):1433-1437. 被引量:2
-
3中国2型糖尿病防治指南(2013年版)[J].中国医学前沿杂志(电子版),2015,7(3):26-89. 被引量:785
-
4王悦尧,王永辉,柴智,刘必旺,周然.DNA甲基化与2型糖尿病的研究进展[J].世界中西医结合杂志,2015,10(8):1178-1181. 被引量:4
-
5代雅琪,张博洋,朱丽叶,唐小革,许文涛.DNA甲基化检测方法研究进展[J].农业生物技术学报,2017,25(1):150-158. 被引量:12
-
6成淑英,李楠,张利红,田竹芳.血管细胞黏附分子-1与2型糖尿病大血管病变关系研究[J].陕西医学杂志,2017,46(7):902-904. 被引量:8
二级引证文献3
-
1屈玲玲,邹琴,李清璇,李晓颖,刘忠强,周宇霞,郭兵,石明隽.高糖促进小鼠肾小管上皮细胞DNMT3B表达并通过激活β-catenin信号通路促进纤维化相关蛋白分泌[J].细胞与分子免疫学杂志,2021,37(7):608-615. 被引量:2
-
2樊垚,王强,唐吉宏,娄青林,唐伟,顾刘宝.老年2型糖尿病病人心血管病死亡相关外周血全基因组DNA甲基化的研究[J].实用老年医学,2022,36(5):468-472.
-
3吴越,杨宗军,徐瑛蕾,张璐,潘月帅,魏丽丽.妊娠期糖尿病患者外周血NOX 5基因甲基化检测[J].精准医学杂志,2023,38(1):77-80.
-
1糖尿病患者注射胰岛素会使胰岛功能衰退吗?[J].祝您健康,2016,0(11):28-28.
-
2王鸿武,林丽敏.糖尿病酮症酸中毒儿童血脂异常与胰岛功能改变的临床观察[J].实用临床医学(江西),2016,17(11):54-56. 被引量:3
-
3贾红蔚.文迪雅与胰岛素合用治疗2型糖尿病的疗效观察[J].中原医刊,2002,29(7):17-18.
-
4王慧,娄晋宁.糖尿病微血管病变机制的研究进展[J].医学研究杂志,2010,39(8):101-104. 被引量:41
-
5陈煜.胖糖友更易惹上并发症[J].医药前沿,2012,2(7):61-61.
-
6李香兮.2型糖友体重超标怎么办?[J].人人健康,2013(1):37-37. 被引量:1
-
7王玉珍.高胰岛素血症,福兮?祸兮?[J].糖尿病之友,2007(6):36-36.
-
8金晖.糖尿病人群何时使用胰岛素[J].医药与保健,2013(6):34-34. 被引量:1
-
9佘桂爵.为胰岛素说公道话[J].家庭中医药,2009(1):31-31. 被引量:1
-
10姚颖.瑞格列奈与格列奇特治疗2型糖尿病疗效观察[J].山西医药杂志(上半月),2010,39(10):959-960. 被引量:1